Shedding new light on Tourette's syndrome
PA47/06 — March 21 2006
New findings of research into Tourette's syndrome could help to pinpoint the cause of the condition.
University of Nottingham researchers have found evidence for an unexpected conclusion that people with Tourette's syndrome actually have more control over some brain processes than people unaffected by the condition.
It has been a widely held view that Tourette's a condition that affects thousands of Britons and can seriously inhibit social interaction is the result of the failure of control systems in the brain.
Though the repetitive vocal and physical tics characteristic of Tourette's suggest an inability to control involuntary actions at the cognitive level, the latest findings contradict this and suggest the opposite may be the case. The Nottingham researchers have found evidence that young people with Tourette's syndrome actually exhibit a greater level of cognitive control over their movements and speech than their non-affected peers do.
The constant need to suppress tics may have enhanced the brain processes that normally inhibit unwanted movement and speech, researchers believe.
The research findings offer new clues as to which regions of the brain may be involved in the generation of the syndrome's characteristic behavioural tics. Dr Georgina Jackson and colleagues at The University of Nottingham report their findings in the March 21 issue of the journal Current Biology.
Tourette's syndrome is a developmental disorder that typically occurs during late childhood and is characterised by the presence of chronic vocal and physical tics. Tics are involuntary, repetitive, highly stereotyped behaviours that occur with a limited duration, typically occur many times during a single day, and occur on most days.
Physical tics can be simple or complex in appearance, ranging from simple repetitive movements to coordinated action sequences. Verbal tics may involve repeating words or utterances (known as palilalia), producing inappropriate or obscene utterances (coprolalia), or the repetition of another's words (echolalia).
Understanding the psychological processes and neural mechanisms that give rise to the execution of tics is of considerable clinical importance. A widely held view is that the inability to suppress unwanted movements in Tourette's syndrome results from a failure of cognitive control mechanisms.
In the new work, Dr Jackson and colleagues studied cognitive control mechanisms in a group of young people with Tourette's syndrome (TS) by assessing the performance of individuals on a goal-oriented eye-movement task.
The task demanded high levels of voluntary control and the active inhibition of automatic eye movements. The researchers found that in performing the task, TS individuals are not in fact impaired in cognitive control. Instead, the study showed that, paradoxically, TS individuals make fewer error responses than their age-matched and neurologically normal peers do, while responding just as fast to the task's demands.
According to Dr Jackson and colleagues, this finding most likely reflects a compensatory change in TS individuals whereby chronic suppression of tics results in a generalised suppression of reflexive behaviour in favour of increased cognitive control.
Dr Jackson said: The findings are tremendously exciting and provide an important advance in our understanding of the behavioural consequences of Tourette's syndrome.
Our current work is using ultra high-field brain imaging (MRI) techniques to understand the neural correlates of these behavioural changes. We would like to thank the Tourette's patients and their families for their continued help with our research programme.
Dr Jackson's work on Tourette's syndrome has received further recognition this week with the award of a $75,000 (£43,000) research grant from the Tourette's Syndrome Association USA.
According to the Tourette's Syndrome Association, there are around 29,000 people in the UK with the condition.
It is named for French neurologist Dr George Gilles de la Tourette, who made the first clinical report of the condition, in 1885.
Ends
Notes to editors: The University of Nottingham undertakes world-changing research and provides teaching of the highest quality. Ranked in the THES World Top 100 Universities, its academics have won two Nobel Prizes since 2003. An international institution, the University has campuses in the United Kingdom, Malaysia and China.
More information is available from Dr Georgina Jackson, Division of Psychiatry, University of Nottingham, on +44 (0)115 823 0416, georgina.jackson@nottingham.ac.uk; or Media Relations Manager Tim Utton in the University's Public Affairs Office on +44 (0)115 846 8092, tim.utton@nottingham.ac.uk |
